European Pharmacopoeia Equivalent Texts

In monographs reproduced from the European Pharmacopoeia the analytical methods, tests and other supporting texts are invoked by means of the reference number of the text in the General Chapters of the European Pharmacopoeia.

The table below lists the contents of the General Chapters of the European Pharmacopoeia and gives the British Pharmacopoeia or British Pharmacopoeia (Veterinary) equivalents. It is provided for information but it is emphasised that, for texts of the European Pharmacopoeia, in cases of doubt or dispute the text published by the Council of Europe is authoritative. Appendices of the British Pharmacopoeia (Veterinary) are identified by inclusion of ‘(Vet)’ after the Appendix letter, for example, Appendix XV J (Vet)1.

Ph. Eur.	Subject of text	British Pharmacopoeia reference
1	General Notices	⁽¹⁾
2.1.1	Droppers	Appendix I A
2.1.2	Sintered-glass Filters	Appendix XVII B2
2.1.3	UV lamps	Appendix III A
2.1.4	Sieves	Appendix XVII B1
2.1.5	Tubes for Comparative Tests	Appendix VII
2.1.6	Gas detector tubes	Appendix IX K
2.2.1	Clarity and Degree of Opalescence of Liquids	Appendix IV A
2.2.2	Degree of Coloration of Liquids	Appendix IV B
2.2.3	Potentiometric Determination of pH	Appendix V L
2.2.4	Approximate pH of Solutions	Appendix V K
2.2.5	Relative Density	Appendix V G
2.2.6	Refractive Index	Appendix V E
2.2.7	Optical Rotation	Appendix V F
2.2.8	Viscosity	Appendix V H
2.2.9	Capillary Viscometer Method	Appendix V H, Method II
2.2.10	Rotating Viscometer Method	Appendix V H, Method III
2.2.11	Distillation Range	Appendix V C
2.2.12	Boiling Point	Appendix V D
2.2.13	Water by Distillation Range	Appendix IX C, Method II
2.2.14	Melting point: Capillary Method	Appendix V A, Method I
2.2.15	Melting point: Open Capillary Method	Appendix V A, Method IV
2.2.16	Melting point: Instantaneous Method	Appendix V A, Method V
2.2.17	Drop Point	Appendix V A, Method III
2.2.18	Freezing Point	Appendix V B
2.2.19	Amperometric Titration	Appendix VIII B
2.2.20	Potentiometric Titration	Appendix VIII B
2.2.21	Fluorimetry	Appendix II E
2.2.22	Atomic Emission Spectrometry	Appendix II D
2.2.23	Atomic Absorption Spectrometry	Appendix II D
2.2.24	Infrared Spectrophotometry	Appendix II A
2.2.25	Visible and Ultraviolet Spectrophotometry	Appendix II B
2.2.26	Paper Chromatography	Appendix III E
2.2.27	Thin-layer Chromatography	Appendix III A
2.2.28	Gas Chromatography	Appendix III B
2.2.29	Liquid Chromatography	Appendix III D
2.2.30	Size-exclusion Chromatography	Appendix III C
2.2.31	Electrophoresis	Appendix III F
2.2.32	Loss on Drying	Appendix IX D
2.2.33	Nuclear Magnetic Resonance Spectrometry	Appendix II C
2.2.34	Thermogravimetry	Appendix V M
2.2.35	Osmolality	Appendix V N
2.2.36	Ion-selective Potentiometry	Appendix VIII E
2.2.37	X-ray Fluorescent Spectrophotometry	Appendix II F
2.2.38	Conductivity	Appendix V O
2.2.39	Molecular Mass Distribution in Dextrans	Appendix III C
2.2.40	Near-Infrared Spectroscopy	Appendix II A
2.2.41	Circular Dichroism	Appendix V J
2.2.42	Density of Solids	Appendix V Q
2.2.43	Mass Spectrometry	Appendix II G
2.2.44	Total Organic Carbon in Water	Appendix V P
2.2.45	Supercritical Fluid Chromatography	Appendix III H
2.2.46	Chromatographic Separation Techniques	Appendix III
2.2.47	Capillary Electrophoresis	Appendix III G
2.2.48	Raman Spectroscopy	Appendix II H
2.2.49	Falling Ball Viscometer Method	Appendix V H, Method IV
2.2.54	Isoelectric Focussing	Appendix III J
2.2.55	Peptide Mapping	Appendix III K
2.2.56	Amino Acid Analysis	Appendix III L
2.2.57	Inductively Coupled Plasma-Atomic Emission Spectrometry	Appendix II D
2.2.58	Inductively Coupled Plasma-Mass Spectrometry	Appendix II G1
2.2.59	Glycan Analysis of Glycoproteins	Appendix III M
2.2.60	Vacant
2.2.61	Characterisation of Crystalline Solids by Microcalorimetry and Solution Calorimetry	Appendix XVII V
2.2.64	Peptide Identification by Nuclear Magnetic Resonance Spectrometry	Appendix II K
2.2.65	Voltametric Titration	Appendix VIII B
2.2.66	Detection and Measurement of Radioactivity	Appendix V R
2.3.1	Identification Reactions	Appendix VI
2.3.2	Identification of Fatty Oils by TLC	Appendix X N
2.3.3	Identification of Phenothiazines by TLC	Appendix III A
2.3.4	Odour	Appendix VI
	Limit test for:
2.4.1	– Ammonium	Appendix VII
2.4.2	– Arsenic	Appendix VII
2.4.3	– Calcium	Appendix VII
2.4.4	– Chlorides	Appendix VII
2.4.5	– Fluorides	Appendix VII
2.4.6	– Magnesium	Appendix VII
2.4.7	– Magnesium and Alkaline-earth Metals	Appendix VII
2.4.8	– Heavy Metals	Appendix VII
2.4.9	– Iron	Appendix VII
2.4.10	– Lead in Sugars	Appendix VII
2.4.11	– Phosphates	Appendix VII
2.4.12	– Potassium	Appendix VII
2.4.13	– Sulfate	Appendix VII
2.4.14	Sulfated Ash	Appendix IX A, Method II
2.4.15	Limit test for Nickel in Polyols	Appendix VII
2.4.16	Total Ash	Appendix XI J, Method II
2.4.17	Limit test for Aluminium	Appendix VII
2.4.18	Free Formaldehyde	Appendix XV D
2.4.19	Alkaline Impurities in Fatty Oils	Appendix X N
2.4.20	Determination of Metal Catalyst or Metal Reagent Residues	Appendix VIII W
2.4.21	Foreign Oils in Fatty Oils by TLC	Appendix X N
2.4.22	Composition of Fatty Acids by Gas Chromatography	Appendix X N
2.4.23	Sterols in Fatty Oils	Appendix X Q
2.4.24	Residual Solvents	Appendix VIII L
2.4.25	Residual Ethylene Oxide and Dioxan	Appendix VIII M
2.4.26	N,N-Dimethylaniline	Appendix VIII N
2.4.27	Heavy Metals in Herbal Drugs and Fatty Oils	Appendix VII
2.4.28	2-Ethylhexanoic acid	Appendix VIII O
2.4.29	Composition of Fatty Acids in Oils Rich in Omega-3-acids	Appendix X P1
2.4.30	Ethylene Glycol and Diethylene Glycol in Ethoxylated Substances	Appendix VIII K
2.4.31	Nickel in Hydrogenated Vegetable Oils	Appendix VIII R
2.4.32	Total Cholesterol in Oils Rich in Omega-3 Acids	Appendix X P2
2.5.1	Acid Value	Appendix X B
2.5.2	Ester Value	Appendix X C
2.5.3	Hydroxyl Value	Appendix X D
2.5.4	Iodine Value	Appendix X E
2.5.5	Peroxide Value	Appendix X F
2.5.6	Saponification Value	Appendix X G, Method II
2.5.7	Unsaponifiable Matter	Appendix X H, Method II
2.5.8	Assay of Primary Aromatic Amino Nitrogen	Appendix VIII B
2.5.9	Semi-micro Determination of Nitrogen by Sulfuric Acid Digestion	Appendix VIII H
2.5.10	Oxygen-flask Method	Appendix VIII C
2.5.11	Complexometric Titrations	Appendix VIII D
2.5.12	Semi-micro Determination of Water	Appendix IX C, Method I
2.5.13	Aluminium in Adsorbed Vaccines	Appendix XV B
2.5.14	Calcium in Adsorbed Vaccines	Appendix XV C
2.5.15	Phenol in Immunosera and Vaccines	Appendix XV E
	Polysaccharide Vaccines:
2.5.16	– Protein	Appendix XV G
2.5.17	– Nucleic Acids	Appendix XV G
2.5.18	– Phosphorus	Appendix XV G
2.5.19	– O-acetyl	Appendix XV G
2.5.20	– Hexosamines	Appendix XV G
2.5.21	– Methylpentoses	Appendix XV G
2.5.22	– Uronic Acids	Appendix XV G
2.5.23	– Sialic Acid	Appendix XV G
2.5.24	Carbon Dioxide in Medicinal Gases	Appendix IX F
2.5.25	Carbon Monoxide in Medicinal Gases	Appendix IX E
2.5.26	Nitrogen Monoxide and Nitrogen Dioxide in Medicinal Gases	Appendix IX G
2.5.27	Oxygen in Medicinal Gases	Appendix IX H
2.5.28	Water in Medicinal Gases	Appendix IX J
2.5.29	Sulfur Dioxide	Appendix IX B, Method II
2.5.30	Oxidising Substances	Appendix X L
2.5.31	Ribose in Polysaccharide Vaccines	Appendix XV G
2.5.32	Micro Determination of Water	Appendix IX C, Method III
2.5.33	Total Protein Assay	Appendix VIII P
2.5.34	Acetic Acid in Synthetic Peptides	Appendix VIII Q
2.5.35	Nitrous Oxide in Gases	Appendix IX L
2.5.36	Anisidine value	Appendix X O
2.5.37	Methyl, Ethyl and Isopropyl Methanesulfonate in Methanesulfonic Acid	Appendix VIII S
2.5.38	Methyl, Ethyl and Isopropyl Methanesulfonate in Active Substances	Appendix VIII T
2.5.39	Methanesulfonyl Chloride in Methanesulfonic Acid	Appendix VIII V
2.5.40	Methyl, Ethyl and Isopropyl Toluenesulfonate in Active Substances	Appendix VIII X
2.5.41	Methyl, Ethyl and Isopropyl Benzenesulfonate in Active Substances	Appendix VIII Y
2.6.1	Sterility	Appendix XVI A
2.6.2	Mycobacteria	Appendix XVI B4
2.6.3	Vacant
2.6.4	Vacant
2.6.5	Vacant
2.6.6	Vacant
2.6.7	Mycoplasmas	Appendix XVI B3 and Appendix XVI B(Vet)3
2.6.8	Pyrogens	Appendix XIV D
2.6.9	Abnormal Toxicity	Appendix XIV E
2.6.10	Histamine	Appendix XIV G
2.6.11	Depressor Substances	Appendix XIV F
2.6.12	Microbiological Examination of Non-sterile Products: Microbial Enumeration Tests	Appendix XVI B2
2.6.13	Microbiological Examination of Non-sterile Products: Test for Specified Micro-organisms	Appendix XVI B1
2.6.14	Bacterial Endotoxins	Appendix XIV C
2.6.15	Prekallikrein Activator	Appendix XIV J A9
2.6.16	Extraneous Agents in Viral Vaccines	Appendix XVI B5
2.6.17	Anticomplementary Activity of Immunoglobulins	Appendix XIV J C2
2.6.18	Neurovirulence of Live Viral Vaccines	Appendix XV F1
2.6.19	Neurovirulence of Poliomyelitis Vaccine (Oral)	Appendix XV F2
2.6.20	Anti-A and Anti-B Haemagglutinins	Appendix XIV J C5
2.6.21	Nucleic Acid Amplification	Appendix XIV L
2.6.22	Activated Coagulation Factors	Appendix XIV J A7
2.6.24	Avian Viral Vaccines: Tests for Extraneous Agents in Seed Lots	Appendix XVI B(Vet)4
2.6.25	Avian Live Virus Vaccines: Tests for Extraneous Agents in Batches of Finished Product	Appendix XVI B(Vet)5
2.6.26	Test for Anti-D Antibodies in Human Immunoglobulin	Appendix XIV J C4
2.6.27	Microbiological Control of Cellular Products	Appendix XVI E
2.6.30	Monocyte-Activation Test	Appendix XIV H
2.6.31	Microbiological Examination of Herbal Medicinal Products for Oral Use and Extracts used in their Preparations	Appendix XVI F
2.6.33	Residual Pertussis Toxin and Irreversibility of Pertussis Toxoid	Appendix XIV K9
2.6.34	Host-cell Protein Assays	Appendix XIV O
2.7.1	Immunochemical Methods	Appendix XIV B
2.7.2	Microbiological Assay of Antibiotics	Appendix XIV A
2.7.3	Vacant
2.7.4	Assay of Coagulation Factor VIII	Appendix XIV J A3
2.7.5	Assay of Heparin	Appendix XIV J B2
2.7.6	Assay of Diphtheria Vaccine (Adsorbed)	Appendix XIV K1
2.7.7	Assay of Pertussis Vaccine (Whole Cell)	Appendix XIV K2
2.7.8	Assay of Tetanus Vaccine (Adsorbed)	Appendix XIV K3
2.7.9	Fc Function of Immunoglobulins	Appendix XIV J C1
2.7.10	Assay of Human Coagulation Factor VII	Appendix XIV J A2
2.7.11	Assay of Coagulation Factor IX	Appendix XIV J A4
2.7.12	Assay of Heparin in Coagulation Factors	Appendix XIV J B1
2.7.13	Assay of Anti-D Immunoglobulin	Appendix XIV J C3
2.7.14	Assay of Hepatitis A Vaccine	Appendix XIV K4
2.7.15	Assay of Hepatitis B (rDNA) Vaccine	Appendix XIV K5
2.7.16	Assay of Pertussis Vaccine (Acellular)	Appendix XIV K6
2.7.17	Assay of Human Antithrombin III	Appendix XIV J B3
2.7.18	Assay of Human Coagulation Factor II	Appendix XIV J A1
2.7.19	Assay of Human Coagulation Factor X	Appendix XIV J A5
2.7.20	In vivo Assay of Poliomyelitis Vaccine (Inactivated)	Appendix XIV K7
2.7.21	Assay of Human von Willebrand factor	Appendix XIV J A8
2.7.22	Assay of Human Coagulation Factor XI	Appendix XIV J A6
2.7.23	Numeration of CD34/CD45+ Cells in Haematopoietic Products	Appendix XIV N
2.7.24	Flow Cytometry	Appendix II J
2.7.25	Assay of Human Plasmin Inhibitor	Appendix XIV J A10
2.7.27	Flocculation Value (Lf) of Diphtheria and Tetanus Toxins and Toxoids (Ramon Assay)	Appendix XIV K8
2.7.28	Colony-forming Cell Assay for Human Haematopoietic Progenitor Cells	Appendix XIV N2
2.7.29	Nucleated Cell Count and Viability	Appendix XIV N3
2.7.30	Assay of Human Protein C	Appendix XIV J B4
2.7.31	Assay of Human Protein S	Appendix XIV J B5
2.7.32	Assay of Human α-1-Proteinase Inhibitor	Appendix XIV J D1
2.7.34	Assay of Human C1-esterase Inhibitor	Appendix XIV J D2
2.7.35	Immunonephelometry for Vaccine Component Assay	Appendix XV L
2.8.1	Ash Insoluble in Hydrochloric Acid	Appendix XI K, Method II
2.8.2	Foreign Matter	Appendix XI D
2.8.3	Stomata and Stomatal Index	Appendix XI H
2.8.4	Swelling Index	Appendix XI C
2.8.5	Water in Essential Oils	Appendix X M
2.8.6	Foreign Esters	Appendix X M
2.8.7	Fatty Oils and Resinified Volatile Oils	Appendix X M
2.8.8	Odour and Taste of Volatile Oils	Appendix X M
2.8.9	Residue on Evaporation	Appendix X M
2.8.10	Solubility in Ethanol (Volatile Oils)	Appendix X M
2.8.11	Determination of Cineole	Appendix X J
2.8.12	Essential Oils in Herbal Drugs	Appendix XI E
2.8.13	Pesticide Residues	Appendix XI L
2.8.14	Tannins in Herbal Drugs	Appendix XI M
2.8.15	Bitterness value	Appendix XI N
2.8.16	Dry Residue of Extracts	Appendix XI P
2.8.17	Loss on Drying of Extracts	Appendix XI Q
2.8.18	Determination of Aflatoxin B₁ in Herbal Drugs	Appendix XI S1
2.8.20	Herbal Drugs: Sampling and Sample Preparation	Appendix XI T
2.8.21	Test for Aristolochic Acids in Herbal Drugs	Appendix XI R1
2.8.22	Determination of Ochratoxin A in Herbal Drugs	Appendix XI S2
2.8.23	Microscopic Examination of Herbal Drugs	Appendix XI U
2.8.24	Vacant
2.8.25	High-performance Thin-Layer Chromatography of Herbal Drugs and Herbal Drug Preparations	Appendix XI W
2.9.1	Disintegration of Tablets and Capsules	Appendix XII A1
2.9.2	Disintegration of Suppositories and Pessaries	Appendix XII A2
2.9.3	Dissolution Test for Solid Dosage Forms	Appendix XII B1
2.9.4	Dissolution Test for Transdermal Patches	Appendix XII B2
2.9.5	Uniformity of Mass	Appendix XII C1
2.9.6	Uniformity of Content	Appendix XII C3
2.9.7	Friability of Uncoated Tablets	Appendix XVII G1
2.9.8	Resistance to Crushing of Tablets	Appendix XVII H
2.9.9	Measurement of Consistency by Penetrometry	Appendix XVII F
2.9.10	Ethanol Content	Appendix VIII F, Method III
2.9.11	Methanol and 2-propanol	Appendix VIII G
2.9.12	Particle Size Classification of Powders (Sieve Test)	Appendix XVII A1
2.9.13	Vacant
2.9.14	Specific Surface Area by Gas Permeability	Appendix XVII C
2.9.15	Vacant
2.9.16	Flowability	Appendix XVII E
2.9.17	Extractable Volume of Parenteral Preparations	Appendix XII C5
2.9.18	Aerodynamic Assessment of Fine Particles	Appendix XII C7
2.9.19	Particulate Contamination: Sub-visible Particles	Appendix XIII A
2.9.20	Particulate Contamination: Visible Particles	Appendix XIII B
2.9.21	Vacant
2.9.22	Softening Time of Lipophilic Suppositories	Appendix XVII J
2.9.23	Pycnometric Density of Solids	Appendix XVII K
2.9.24	Vacant
2.9.25	Dissolution Test for Medicated Chewing Gums	Appendix XII B4
2.9.26	Specific Surface Area By Gas Adsorption	Appendix XVII M
2.9.27	Uniformity of Mass of Delivered Doses from Multidose Containers	Appendix XII C2
2.9.28	Vacant
2.9.29	Intrinsic Dissolution	Appendix XII B5
2.9.31	Particle Size Analysis by Laser Light Diffraction	Appendix XVII P
2.9.32	Porosity and Pore-size Distribution of Solids by Mercury Porosimetry	Appendix XVII R
2.9.33	Characterisation of Crystalline and Partially Crystalline Solids by X-ray Powder Diffraction (XRPD)	Appendix XVII Q
2.9.34	Bulk Density and Tapped Density of Powders	Appendix XVII S
2.9.35	Powder Fineness	Appendix XVII A2
2.9.36	Powder Flow	Appendix XVII N
2.9.37	Optical Microscopy	Appendix XVII O
2.9.38	Particle-size Distribution Estimation by Analytical Sieving	Appendix XVII B3
2.9.39	Water-Solid Interactions: Determination of Sorption-Desorption Isotherms and of Water Activity	Appendix IX M
2.9.40	Uniformity of Dosage Units	Appendix XII C4
2.9.41	Friability of Granules and Spheroids	Appendix XVII G2
2.9.42	Dissolution Test for Lipophilic Solid Dosage Forms	Appendix XII B3
2.9.43	Apparent Dissolution	Appendix XII B6
2.9.44	Preparations for Nebulisation: Characterisation	Appendix XII C8
2.9.45	Wettability of Porous Solids Including Powders	Appendix XVII T
2.9.46	Vacant
2.9.47	Demonstration of Uniformity of Dosage Units Using Larger Sample Sizes	Appendix XII C9
3.1.1	Material Used for Containers for Human Blood and Blood Components	Appendix XX A
3.1.1.1	Materials Based on PVC for Blood and Blood Components	Appendix XX A1
3.1.1.2	Materials Based on PVC for Tubing Used in Sets for the Transfusion of Blood and Blood Components	Appendix XX A2
3.1.3	Polyolefins	Appendix XX B
3.1.4	Polyethylene – Without Additives	Appendix XX C1
3.1.5	Polyethylene – With Additives	Appendix XX C2
3.1.6	Polypropylene	Appendix XX D
3.1.7	Poly(ethylene–vinyl acetate)	Appendix XX E
3.1.8	Silicone Oil Used as a Lubricant	Appendix XX F1
3.1.9	Silicone Elastomer for Closures and Tubing	Appendix XX F2
3.1.10	Materials Based on Non-plasticised PVC for Containers for Non-injectable, Aqueous Solutions	Appendix XX A3
3.1.11	Materials Based on Non-plasticised Poly(vinyl chloride) for Containers for Solid Dosage forms for Oral Administration	Appendix XX A4
3.1.12	Vacant
3.1.13	Plastic Additives	Appendix XX G
3.1.14	Materials Based on Plasticised Poly(vinyl chloride) for Containers for Aqueous Solutions for Intravenous Infusion	Appendix XX A5
3.1.15	Polyethylene Terephthalate for Containers for Preparations Not for Parenteral Use	Appendix XX H
3.2	Containers	Appendix XIX A
3.2.1	Glass Containers for Pharmaceutical Use	Appendix XIX B
3.2.2	Plastic Containers and Closures	Appendix XIX C
3.2.2.1	Plastic Containers for Aqueous Solutions for Parenteral Infusions	Appendix XIX C1
3.2.3	Sterile Plastic Containers for Blood and Blood Components	Appendix XIX D1
3.2.4	Empty Sterile Plastic Containers for Blood and Blood Components	Appendix XIX D2
3.2.5	Sterile Plastic Containers with Anticoagulant for Blood and Blood Components	Appendix XIX D3
3.2.6	Sets for the Transfusion of Blood and Blood Components	Appendix XIX F
3.2.7	Vacant
3.2.8	Sterile Single-Use Plastic Syringes	Appendix XIX G
3.2.9	Rubber Closures for Containers for Aqueous Preparations for Parenteral Use	Appendix XIX E
4.1.1	Reagents	Appendix I A
4.1.2	Standard Solutions	Appendix I C
4.1.3	Buffer Solutions	Appendix I D
4.2.1	Reference Substances for Volumetric Solutions	Appendix I B
4.2.2	Volumetric Solutions	Appendix I B
5.1.1	Methods of Preparation of Sterile Products	Appendix XVIII
5.1.2	Biological Indicators (sterilisation)	Appendix XVIII
5.1.3	Efficacy of Antimicrobial Preservation	Appendix XVI C
5.1.4	Microbiological Quality of Non-sterile Pharmaceutical Preparations and Substances for Pharmaceutical Use	Appendix XVI D
5.1.5	F₀ Concept (sterilisation)	Appendix XVIII
5.1.6	Alternative Methods for Control of Microbiological Quality	Supplementary Chapter IV L
5.1.7	Viral Safety	Appendix XXII A
5.1.8	Microbiological Quality of Herbal Medicinal Products for Oral Use and Extracts used in their Preparation	Appendix XVI G
5.1.9	Guidelines for using the Test for Sterility	Supplementary Chapter IV P
5.1.10	Guidelines for using the test for bacterial endotoxins	Supplementary Chapter I C
5.1.11	Determination of Bactericidal, Fungicidal or Yeasticidal Activity of Antiseptic Medicinal Products	Appendix XIV P
5.2.1	Terminology: Vaccines	Appendix XV A and Appendix XV A(Vet)
5.2.2	SPF Chicken Flocks	Appendix XV H and Appendix XV H(Vet)
5.2.3	Cell Substrates for the Production of Vaccines for Human Use	Appendix XV J
5.2.4	Cell Cultures (Veterinary Vaccine Production)	Appendix XV J(Vet)1
5.2.5	Substances of Animal Origin for the Production of Immunological Veterinary Medicinal Products	Appendix XV J(Vet)2
5.2.6	Safety: Veterinary Vaccines	Appendix XV K(Vet)1
5.2.7	Efficacy: Veterinary Vaccines	Appendix XV K(Vet)2
5.2.8	Minimising the Risk of Transmitting Animal Spongiform Encephalopathy Agents via Medicinal Products	Appendix XXII B
5.2.9	Evaluation of Safety of Each Batch of Immunosera for Veterinary Use	Appendix XV K(Vet)3
5.2.11	Carrier Proteins for the Production of Conjugated Polysaccharide Vaccines for Human Use	Appendix XV K
5.2.12	Raw Materials of Biological Origin for the Production of Cell-based and Gene Therapy Medicinal Products	Supplementary Chapter IV S
5.2.13	Healthy Chicken Flocks for the Production of Inactivated Vaccines for Veterinary Use	Appendix XV(Vet)1
5.3	Statistical Analysis of Biological Assays and Tests	Supplementary Chapter IV G
5.4	Residual Solvents	Supplementary Chapter IV D
5.5	Alcoholimetric Tables	Supplementary Chapter IV E
5.6	Assay of Interferons	Appendix XIV M1
5.7	Physical Characteristics of Radionuclides	Radiopharmaceutical Preparations
5.8	Pharmacopoeial Harmonisation	Supplementary Chapter IV F
5.9	Polymorphism	Appendix I F
5.10	Control of Impurities in Substances for Pharmaceutical Use	Supplementary Chapter IV J
5.11	Characters Section in Monographs	Supplementary Chapter IV K
5.12	Reference Standards	Supplementary Chapter IV M
5.14	Gene Transfer Medicinal Products for Human Use	Supplementary Chapter IV N
5.16	Crystallinity	Appendix XVII U
5.17.1	Recommendations on dissolution testing	Appendix XII B1
5.19	Extemporaneous Preparation of Radiopharmaceuticals	Radiopharmaceutical Preparations
5.20	Metal Catalyst or Metal Reagent Residues	Supplementary Chapter IV Q
5.21	Chemometric Methods Applied to Analytical Data	Supplementary Chapter IV R
5.22	Names of Herbal Drugs Used in Traditional Chinese Medicine	Supplementary Chapter VII B
5.23	Monographs on Herbal Drug Extracts (Information Chapter)	Supplementary Chapter VII C

⁽¹⁾ Reproduced in full as Part III of the General Notices of the British Pharmacopoeia and British Pharmacopoeia (Veterinary).